Auro Laboratories Limited (AUROLAB.BO)
INR 246.3
(-0.5%)
INR 246.3
(-0.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 121.73 Million INR | 128.23% |
| 2022 | 43.92 Million INR | -5.96% |
| 2021 | 57.17 Million INR | -52.73% |
| 2020 | 119.99 Million INR | 66.74% |
| 2019 | 72.43 Million INR | -7.74% |
| 2018 | 68.42 Million INR | 15.61% |
| 2017 | 67.46 Million INR | 38.83% |
| 2016 | 48.59 Million INR | 55.77% |
| 2015 | 31.19 Million INR | 1.64% |
| 2014 | 30.69 Million INR | 16.23% |
| 2013 | 26.4 Million INR | -14.44% |
| 2012 | 30.86 Million INR | 54.15% |
| 2011 | 20.02 Million INR | 19.56% |
| 2010 | 16.74 Million INR | 122.48% |
| 2009 | 7.52 Million INR | 22.7% |
| 2008 | 6.13 Million INR | 38.0% |
| 2007 | 4.44 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 15.25 Million INR | -45.66% |
| 2023 Q4 | 28.08 Million INR | -37.63% |
| 2023 Q1 | 15.17 Million INR | -48.91% |
| 2023 Q2 | 33.45 Million INR | 120.4% |
| 2023 FY | - INR | 128.23% |
| 2023 Q3 | 45.02 Million INR | 34.61% |
| 2022 FY | - INR | -5.96% |
| 2022 Q2 | 8.61 Million INR | 37.53% |
| 2022 Q1 | 6.26 Million INR | -44.96% |
| 2022 Q4 | 29.7 Million INR | 239.02% |
| 2022 Q3 | 8.76 Million INR | 1.74% |
| 2021 Q4 | 11.37 Million INR | -8.22% |
| 2021 Q2 | 14.19 Million INR | -24.34% |
| 2021 Q3 | 12.39 Million INR | -12.64% |
| 2021 FY | - INR | -52.73% |
| 2021 Q1 | 18.75 Million INR | -41.51% |
| 2020 Q1 | 22.41 Million INR | 112.42% |
| 2020 FY | - INR | 66.74% |
| 2020 Q4 | 32.06 Million INR | 3.02% |
| 2020 Q3 | 31.12 Million INR | -9.48% |
| 2020 Q2 | 34.38 Million INR | 53.39% |
| 2019 Q4 | 10.55 Million INR | -37.63% |
| 2019 Q1 | 19.28 Million INR | -27.54% |
| 2019 Q2 | 24.08 Million INR | 24.92% |
| 2019 Q3 | 16.92 Million INR | -29.76% |
| 2019 FY | - INR | -7.74% |
| 2018 Q4 | 26.61 Million INR | 15.44% |
| 2018 Q2 | 15.13 Million INR | 14.57% |
| 2018 FY | - INR | 15.61% |
| 2018 Q1 | 13.2 Million INR | -42.8% |
| 2018 Q3 | 23.05 Million INR | 52.37% |
| 2017 Q2 | 14.41 Million INR | 49.72% |
| 2017 Q4 | 23.08 Million INR | 13.52% |
| 2017 Q3 | 20.33 Million INR | 41.06% |
| 2017 FY | - INR | 38.83% |
| 2017 Q1 | 9.62 Million INR | -49.31% |
| 2016 Q4 | 18.99 Million INR | 114.69% |
| 2016 FY | - INR | 55.77% |
| 2016 Q3 | 8.84 Million INR | 7.97% |
| 2016 Q2 | 8.19 Million INR | -22.89% |
| 2016 Q1 | 10.62 Million INR | 7.26% |
| 2015 Q3 | 7.08 Million INR | 3.96% |
| 2015 Q4 | 9.9 Million INR | 39.92% |
| 2015 FY | - INR | 1.64% |
| 2015 Q1 | 7.39 Million INR | -22.67% |
| 2015 Q2 | 6.81 Million INR | -7.9% |
| 2014 FY | - INR | 16.23% |
| 2014 Q4 | 9.56 Million INR | 24.84% |
| 2014 Q3 | 7.66 Million INR | 6.7% |
| 2014 Q1 | 6.28 Million INR | 3.68% |
| 2014 Q2 | 7.18 Million INR | 14.17% |
| 2013 Q2 | 7.03 Million INR | 2.19% |
| 2013 Q4 | 6.06 Million INR | -5.56% |
| 2013 Q1 | 6.88 Million INR | 23.95% |
| 2013 FY | - INR | -14.44% |
| 2013 Q3 | 6.42 Million INR | -8.7% |
| 2012 Q3 | 8.47 Million INR | -16.67% |
| 2012 Q1 | 6.67 Million INR | 65.17% |
| 2012 Q2 | 10.16 Million INR | 52.33% |
| 2012 Q4 | 5.55 Million INR | -34.44% |
| 2012 FY | - INR | 54.15% |
| 2011 Q4 | 4.04 Million INR | 2.43% |
| 2011 FY | - INR | 19.56% |
| 2011 Q3 | 3.94 Million INR | 0.0% |
| 2010 FY | - INR | 122.48% |
| 2010 Q4 | 5.55 Million INR | 0.0% |
| 2009 FY | - INR | 22.7% |
| 2008 FY | - INR | 38.0% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -18958.354% |
| Sastasundar Ventures Limited | -203.51 Million INR | 159.817% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -950.898% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | -36.767% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -44.535% |
| Sunil Healthcare Limited | 93.07 Million INR | -30.788% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -636.99% |
| MedPlus Health Services Limited | 3.94 Billion INR | 96.911% |
| Zenith Healthcare Limited | 4.98 Million INR | -2340.577% |
| Patidar Buildcon Limited | -5.52 Million INR | 2302.968% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | -38.996% |
| Roopa Industries Limited | 55.7 Million INR | -118.553% |
| Smruthi Organics Limited | 120.31 Million INR | -1.184% |
| Trident Lifeline Limited | 102.69 Million INR | -18.544% |
| Bacil Pharma Limited | -569.32 Thousand INR | 21482.702% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 198.746% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -666.744% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 180.592% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -347.674% |
| PANJON LTD. | 4.08 Million INR | -2877.158% |
| Tyche Industries Limited | 128.2 Million INR | 5.047% |
| Trimurthi Limited | -2.47 Million INR | 5011.661% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 738.967% |
| Anuh Pharma Limited | 878.5 Million INR | 86.143% |
| Crestchem Limited | 30.33 Million INR | -301.314% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 1225.31% |
| Zenlabs Ethica Limited | 27.09 Million INR | -349.277% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 68.537% |
| ANG Lifesciences India Limited | 90.66 Million INR | -34.275% |
| Parmax Pharma Limited | 22.93 Million INR | -430.729% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 68.704% |
| Deccan Health Care Limited | 37.5 Million INR | -224.577% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 43.795% |
| Norris Medicines Limited | -1.78 Million INR | 6923.212% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 52.105% |
| Veerhealth Care Limited | 15.99 Million INR | -661.088% |
| Makers Laboratories Limited | 25.81 Million INR | -371.626% |
| Lactose (India) Limited | 201.22 Million INR | 39.502% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 226.583% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 28.631% |
| Mercury Laboratories Limited | 101.18 Million INR | -20.307% |
| Gennex Laboratories Limited | 219.35 Million INR | 44.503% |
| PRAVEG LIMITED | 321.43 Million INR | 62.127% |
| Denis Chem Lab Limited | 224.84 Million INR | 45.859% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 80.058% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 67.783% |
| Colinz Laboratories Limited | 5.42 Million INR | -2142.741% |
| Godavari Drugs Limited | 134.62 Million INR | 9.574% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 30084.236% |
| Zenotech Laboratories Limited | 172.64 Million INR | 29.488% |
| Panchsheel Organics Limited | 189.36 Million INR | 35.714% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 72.874% |
| Vivanza Biosciences Limited | 11.2 Million INR | -986.541% |
| Phaarmasia Limited | -1.58 Million INR | 7795.07% |
| Bharat Parenterals Limited | 265.74 Million INR | 54.19% |
| Medi-Caps Limited | 4.77 Million INR | -2451.582% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 4575.588% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 85.351% |
| BDH Industries Limited | 124.27 Million INR | 2.041% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 475.972% |
| Coral Laboratories Limited | 227.07 Million INR | 46.39% |
| Concord Drugs Limited | 40.52 Million INR | -200.434% |
| Beryl Drugs Limited | 26.63 Million INR | -356.984% |
| Evoq Remedies Limited | 6.18 Million INR | -1867.299% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -47.353% |
| Transchem Limited | 56.61 Million INR | -115.039% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -924.024% |
| Parnax Lab Limited | 243.59 Million INR | 50.026% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -171.708% |
| Kerala Ayurveda Limited | 70.78 Million INR | -71.975% |
| Cian Healthcare Limited | 122.56 Million INR | 0.678% |
| Trinity League India Limited | -26.25 Million INR | 563.703% |
| Syschem (India) Limited | 70.4 Million INR | -72.918% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 1519.993% |
| Natural Capsules Limited | 219.9 Million INR | 44.64% |